SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: blankmind who wrote (4893)1/22/1998 12:23:00 AM
From: Tunica Albuginea  Read Replies (1) | Respond to of 23519
 
blankmind, you said it ; shorts are toast. This is the real begininnig
of the now famous, forthcoming short squeeze. This squeeze will be just like I evisioned it: a slow start to 14-15, a little faster to 20.
Then a pause while we are gretting ready to turn the screwa real tight
in Feb with MCA approval. In March we'll recognize large earnings from March shipments to Uk> This will deplete the " product at risl, and management will be working hard at geting 2 and 3 lines going in new facility.That will burst forth in Q2. And then we'll be pushed up by a giant tide of sales, as PMDs and Urologists start dispensing
MUSE in large amounts. When (if ) Viagra comes out the boost will be stronger, more patients in ED therapy. Caveat: if bt any chance , in
March or April, FDA does not approve Viagra PhaseIII study, then look
for a 10 pointer on Vivus that day with rapid rise to 50s.Incidentally 98 EPS will be at least $2 blankmind not 1. First Call and all will continously revise EPSA upwards, all of 98.

All in my modest,or humble, opinion.

TA